Trading Options with an Edge
Select Page

NBIX

Search by
TICKER SYMBOL

Neurocrine Biosciences, Inc.

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing

121.77

-0.38

(-0.311%)

Volume:

158,085

52 week range:

71.88 - 125.99

Market Cap:

11.706B

Company Description:

Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company dedicated to discovering, developing and delivering life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis*, uterine fibroids* and clinical programs in multiple therapeutic areas. For nearly three decades, Neurocrine Biosciences has specialized in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems.